13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 22 holding rows worth $197,602,000.
- Accession
- 0000921895-15-000435
- Filer
- CIK 1587114
- Filed
- 2015-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 22 entries on the cover page, a total value of $197,602,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $197,602,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerNODELMAN OLEG
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KITE PHARMA INC | 49803L109 | COM | 438,400 | $25,283,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 384,348 | $21,523,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 145,801 | $17,862,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 17,500,000 | $16,250,000 | thousands by filing date | principal |
| MACROGENICS INC | 556099109 | COM | 453,626 | $15,909,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 900,000 | $13,788,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 400,000 | $10,936,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 385,124 | $10,133,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 1,294,431 | $9,644,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 491,044 | $9,069,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 589,000 | $8,334,000 | thousands by filing date | call |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,009,752 | $7,937,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 328,070 | $6,479,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 1,986,413 | $4,132,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 201,700 | $4,074,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 207,000 | $3,444,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 157,038 | $3,417,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 78,958 | $3,044,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 100,000 | $2,083,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 619,699 | $1,630,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 160,700 | $1,551,000 | thousands by filing date | call |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 228,400 | $1,080,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-15-000435 | this filing | 2015-02-17 | acceptance time not in the bulk data set |